NOVOZYMES A/S NAM. B DK 2 | 59,060 / +0,72% |
Data / Laikas | 10.08. / 15:48 |
Pok. / Pok.(%) | 0,420 / +0,72% |
Bid | 58,860 / 90 |
Ask | 59,200 / 90 |
Atidaryti | 57,920 |
Ankstesnį uždaryti | 58,640 |
Aukšč. | 59,060 |
Žem. | 57,260 |
APYVARTA [EUR] | - |
APYVARTA [Units] | |
Price fixings | 8 |
ISIN | DK0060336014 |
Simbolis | NZM2 |
Birža | Stuttgart |
Rūšis | Stock |
Visos biržos
Birža | Paskutinis | APYVARTA | |
---|---|---|---|
London Inter.. | 432,00 | ![]() |
192.778 |
Cboe Europe .. | 439,30 | ![]() |
159.606 |
Turquoise | 440,00 | ![]() |
7.579 |
Cboe Europe .. | 439,65 | ![]() |
787 |
Cboe Europe .. | 430,85 | ![]() |
341 |
gettex | 58,940 | ![]() |
89 |
TradeGate | 57,960 | ![]() |
77 |
Frankfurt | 57,4000 | ![]() |
0 |
München | 57,84 | ![]() |
0 |
Düsseldorf | 58,84 | ![]() |
0 |
Berlin | 59,02 | ![]() |
0 |
Vienna Globa.. | 59,16 | ![]() |
0 |
Quotrix | 58,1400 | ![]() |
|
Stuttgart | 59,060 | ![]() |
|
Lang & Schwa.. | 58,90 | ![]() |
|
OMX Nordic | 432,20 | ![]() |
208.471 |
Nasdaq Other.. | 59,3500 | 1.643 |
Naujienos
- Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
01.02.2022 / 08:01 - GlobeNewswire - Closing the gap between sustainability and profits in corn wet milling
16.12.2021 / 10:04 - GlobeNewswire - Novozymes and Saipem enter collaboration agreement to create a more sustainable CO2 capture
13.12.2021 / 08:02 - GlobeNewswire - Novozymes strengthens and accelerates its BioHealth-business by acquiring a majority stake in Synergia Life Sciences, a leading developer and manufacturer of probiotics and vitamin K2-7
30.11.2021 / 10:34 - GlobeNewswire - Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance
26.10.2021 / 13:23 - GlobeNewswire